
Pulmosil 0.8mg Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Sildenafil (0.8mg)
Overview Pulmosil 0.8mg Injection
In pulmonary arterial hypertension, the injectable medication Pulmosil 0.8mg reduces elevated blood pressure within the pulmonary arteries—the vessels transporting blood from the heart to the lungs. This improves exercise capacity. Administration is strictly under medical supervision; discontinuation requires prior consultation to avoid symptom exacerbation. While immediate cessation is not advised for sudden vision loss (one or both eyes) or abrupt hearing loss with tinnitus, prompt medical attention is crucial. Common adverse effects encompass facial flushing, headache, muscle rigidity, and blurred vision; drowsiness or dizziness may also occur. Refrain from operating machinery or driving until the drug's effects are known. Concomitant use with nitrates (frequently prescribed for angina) is hazardous. Pre-existing severe cardiac or hepatic dysfunction, recent stroke or myocardial infarction, or hypotension contraindicate Pulmosil 0.8mg use. Full disclosure of all health conditions is essential before commencing treatment. Dizziness mandates avoidance of driving. Alcohol consumption should be avoided due to potential adverse interactions.
Primary Ingredients of Pulmosil 0.8mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Pulmosil 0.8mg Injection
Managing Erectile Dysfunction
Major Benefits of Pulmosil 0.8mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pulmosil 0.8mg Injection:
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Headache
- Stiffness
- Nosebleeds
- Blurred vision
- Indigestion
- Muscle pain
- Upset stomach
- Rash
How to use Pulmosil 0.8mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Pulmosil 0.8mg Injection works:
Pulmonary hypertension treatment, Pulmosil 0.8mg Injection, functions as a phosphodiesterase-5 (PDE5) inhibitor. Its mechanism involves pulmonary vasodilation, lowering elevated pulmonary arterial pressure. This reduced pressure subsequently lessens the workload on the heart during pulmonary blood circulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Pulmosil 0.8mg Injection poses a safety risk.
PregnancySAFE IF PRESCRIBED
Administration of Pulmosil 0.8mg Injection during gestation is typically deemed safe. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, corresponding data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Pulmosil 0.8mg Injection without significant infant risk. Available human data indicates minimal danger to the nursing child.
DrivingUNSAFE
Administering Pulmosil 0.8mg Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Pulmosil 0.8mg Injection can be administered to patients with kidney impairment without dose modification. Nevertheless, disclosure of pre-existing kidney disease to your physician is advised. Dose reduction might be explored if the injection proves poorly tolerated.
LiverCAUTION
Administering Pulmosil 0.8mg Injection to individuals with severe hepatic impairment requires careful consideration. Dosage modification of Pulmosil 0.8mg Injection may be necessary. Physician consultation is advised. Data regarding Pulmosil 0.8mg Injection use in patients with severe liver disease is scarce.
What if you forget to take Pulmosil 0.8mg Injection :
NA
Facts to Know About Pulmosil 0.8mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzenesulfonamide analog |
| Developing Good Habits | No. |
| Treatment Category | Sexual Enhancement Supplements |
| Actions | PDE5 inhibitors |
